| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Junmo Kim, Eun-Jin Ha, Hee-Soo Kim, Eun-Young Park, Hyung-Chul Lee, Yoon-Hee Choo, Youngbo Shim, Kwangsoo Kim, Keewon Kim, Seung-Bo Le. Real-Time Evaluation of Cerebral Autoregulation Based on Near-Infrared Spectroscopy to Predict Clinical Outcome after Bypass Surgery in Moyamoya Disease. BioMed research international. vol 2022. 2023-05-30. PMID:37251497. |
real-time ca monitoring can predict and thereby help prevent postoperative complications for neurosurgery patients, especially those suffering from moyamoya disease (mmd). |
2023-05-30 |
2023-08-14 |
Not clear |
| Jiawei Xu, Jie Wu, Yu Lei, Yuxiang G. Application of Pseudo-Three-Dimensional Residual Network to Classify the Stages of Moyamoya Disease. Brain sciences. vol 13. issue 5. 2023-05-27. PMID:37239214. |
it is essential to assess the condition of moyamoya disease (mmd) patients accurately and promptly to prevent mmd from endangering their lives. |
2023-05-27 |
2023-08-14 |
Not clear |
| Haibin Wu, Jiang Xu, Jiarong Sun, Jian Duan, Jinlin Xiao, Quan Ren, Pengfei Zhou, Jian Yan, Youping Li, Xiaoxing Xiong, Erming Zen. APOE as potential biomarkers of moyamoya disease. Frontiers in neurology. vol 14. 2023-05-25. PMID:37228412. |
the mechanisms underpinning moyamoya disease (mmd) remain unclear, and effective biomarkers remain unknown. |
2023-05-25 |
2023-08-14 |
Not clear |
| Sherifa Ahmed Hamed, Hosam Abozaid Youse. Idiopathic steno-occlusive disease with bilateral internal carotid artery occlusion: A Case Report. World journal of clinical cases. vol 11. issue 13. 2023-05-23. PMID:37215413. |
moyamoya disease (mmd) is a rare cause of acute stroke and transient ischemic attacks in children. |
2023-05-23 |
2023-08-14 |
Not clear |
| Nishtha Yadav, Hima Pendharkar, Arun Kumar Gupta, Chandrajit Prasad, Dhaval Shukla, Thennarasu Kandavel, Sonia Bansa. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease. Journal of neurosciences in rural practice. vol 14. issue 2. 2023-05-15. PMID:37181159. |
moyamoya disease (mmd) leads to frequent ischemic/hemorrhagic manifestations. |
2023-05-15 |
2023-08-14 |
Not clear |
| Junsheng Li, Qiheng He, Chenglong Liu, Chaofan Zeng, Chuming Tao, Yuanren Zhai, Wei Liu, Qian Zhang, Rong Wang, Yan Zhang, Peicong Ge, Dong Zhang, Jizong Zha. Integrated analysis of the association between methionine cycle and risk of moyamoya disease. CNS neuroscience & therapeutics. 2023-05-15. PMID:37183324. |
the role of methionine (met) cycle in the pathogenesis and progression of cardiovascular and cerebrovascular diseases has been established, but its association with moyamoya disease (mmd) has rarely been studied. |
2023-05-15 |
2023-08-14 |
Not clear |
| Yuanbing Chen, Miao Tang, Yinhua Liang, Hongwei Liu, Junyu Wang, Jun Huan. Transdural collateral circulation indicates cerebral ischemia in Moyamoya disease. World neurosurgery. 2023-05-15. PMID:37187348. |
moyamoya disease (mmd) is an idiopathic occlusive cerebrovascular disorder. |
2023-05-15 |
2023-08-14 |
Not clear |
| Takayuki Kikuchi, Yasushi Takagi, Jyoji Nakagawara, Tsukasa Ueno, Shiho Ubukata, Kiyohiro Houkin, Yoshio Araki, Jun C Takahashi, Hiroyuki Nakase, Toshiya Murai, Susumu Miyamot. Neuronal Loss in the Bilateral Medial Frontal Lobe Revealed by Neurologia medico-chirurgica. 2023-05-10. PMID:37164699. |
neuronal loss in the bilateral medial frontal lobe revealed by cognitive impairment in adult patients with moyamoya disease (mmd) is sometimes overlooked and can occur in patients with no ischemic or hemorrhagic lesions. |
2023-05-10 |
2023-08-14 |
Not clear |
| Erheng Liu, Chengyuan Liu, Lide Jin, Hu Zhou, Xueyi Tan, Guibo Zhang, Weihua Tao, Xiang Gao, Heng Zhao, Chao Luo, Xuehua Li, Shuaifeng Yan. Clinical value of the systemic immune-inflammation index in moyamoya disease. Frontiers in neurology. vol 14. 2023-05-09. PMID:37153657. |
moyamoya disease (mmd) is a rare cerebrovascular disorder with unknown etiology. |
2023-05-09 |
2023-08-14 |
Not clear |
| Erheng Liu, Chengyuan Liu, Lide Jin, Hu Zhou, Xueyi Tan, Guibo Zhang, Weihua Tao, Xiang Gao, Heng Zhao, Chao Luo, Xuehua Li, Shuaifeng Yan. Clinical value of the systemic immune-inflammation index in moyamoya disease. Frontiers in neurology. vol 14. 2023-05-09. PMID:37153657. |
the underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune response may be a potential trigger for mmd. |
2023-05-09 |
2023-08-14 |
Not clear |
| Zhiyang Ma, Dayu Chen, Sheng Wang, Yaozu Zhu, Jincao Che. Increase in age at onset of moyamoya disease in China over 25 years. Brain and behavior. 2023-05-08. PMID:37150963. |
to explore whether the age at onset (aao) of chinese patients with moyamoya disease (mmd) increased over time due to a reduced exposure to leptospiral infection. |
2023-05-08 |
2023-08-14 |
Not clear |
| Kunitaka Maruyama, Daina Kashiwazaki, Shusuke Yamamoto, Naoki Akioka, Emiko Hori, Satoshi Kurod. Coil embolization for post-bypass aneurysm of middle meningeal artery for moyamoya disease - preservation of transdural anastomosis. Surgical neurology international. vol 14. 2023-05-08. PMID:37151426. |
middle meningeal artery (mma) pseudoaneurysm following revascularization surgery for moyamoya disease (mmd) is rare. |
2023-05-08 |
2023-08-14 |
Not clear |
| Tomoaki Suzuki, Hitoshi Hasegawa, Kouichirou Okamoto, Kohei Shibuya, Haruhiko Takahashi, Hidemoto Fujiwara, Makoto Oishi, Yukihiko Fuji. Superior Visualization of Neovascularization with Silent Magnetic Resonance Angiography Compared to Time-of-flight Magnetic Resonance Angiography after Bypass Surgery in Moyamoya Disease. World neurosurgery. 2023-05-06. PMID:37149090. |
the evaluation of postsurgical neoangiogenesis in patients with moyamoya disease (mmd) is crucial for appropriate patient management. |
2023-05-06 |
2023-08-14 |
Not clear |
| Seung Ah Choi, Youn Joo Moon, Eun Jung Koh, Ji Hoon Phi, Ji Yeoun Lee, Kyung Hyun Kim, Seung-Ki Ki. Cyclin-dependent kinase inhibitor 2A (CDKN2A) is a key regulator of cell cycle arrest and senescence in endothelial colony-forming cells (ECFCs) in moyamoya disease (MMD). Journal of Korean Neurosurgical Society. 2023-05-04. PMID:37138505. |
cyclin-dependent kinase inhibitor 2a (cdkn2a) is a key regulator of cell cycle arrest and senescence in endothelial colony-forming cells (ecfcs) in moyamoya disease (mmd). |
2023-05-04 |
2023-08-14 |
Not clear |
| Seung Ah Choi, Youn Joo Moon, Eun Jung Koh, Ji Hoon Phi, Ji Yeoun Lee, Kyung Hyun Kim, Seung-Ki Ki. Cyclin-dependent kinase inhibitor 2A (CDKN2A) is a key regulator of cell cycle arrest and senescence in endothelial colony-forming cells (ECFCs) in moyamoya disease (MMD). Journal of Korean Neurosurgical Society. 2023-05-04. PMID:37138505. |
endothelial colony-forming cells (ecfcs) have been reported to play an important role in the pathogenesis of moyamoya disease (mmd). |
2023-05-04 |
2023-08-14 |
Not clear |
| Junsheng Li, Peicong Ge, Qiheng He, Chenglong Liu, Chaofan Zeng, Chuming Tao, Yuanren Zhai, Jia Wang, Qian Zhang, Rong Wang, Yan Zhang, Dong Zhang, Jizong Zha. Association between methionine sulfoxide and risk of moyamoya disease. Frontiers in neuroscience. vol 17. 2023-05-01. PMID:37123363. |
however, the effects of meto and its association with moyamoya disease (mmd) remained unclear. |
2023-05-01 |
2023-08-14 |
Not clear |
| Yuting Luo, Zhixin Cao, Heng Ye, Shaoqing Wu, Xunsha Su. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study. Journal of neurology. 2023-04-27. PMID:37106259. |
the clinical value of antiplatelet therapy (apt) for moyamoya disease (mmd) remains controversial. |
2023-04-27 |
2023-08-14 |
Not clear |
| Yusuke Egashira, Yukiko Enomoto, Kiyomitsu Kano, Toru Iwam. How I do it: combined bypass for adult moyamoya disease with maximal consideration of cosmetic aspects. Acta neurochirurgica. 2023-04-25. PMID:37097373. |
combined bypass, including direct and indirect procedures, has been recognized as the maximal revascularization to prevent further hemorrhagic or ischemic stroke in adult moyamoya disease (mmd). |
2023-04-25 |
2023-08-14 |
Not clear |
| Toru Tateoka, Hideyuki Yoshioka, Takuma Wakai, Koji Hashimoto, Masakazu Ogiwara, Hiroyuki Kinouch. Analysis of vascular perfusion territory using selective intraarterial injection CT angiography before and after revascularization surgery in patients with moyamoya disease. Journal of neurosurgery. 2023-04-22. PMID:37086162. |
in moyamoya disease (mmd), blood flow to the internal carotid artery (ica) system is supplied via the basal fine vascular network, leptomeningeal anastomoses, and transdural collateral vessels from the external carotid artery (eca). |
2023-04-22 |
2023-08-14 |
Not clear |
| Won-Oak Oh, Il Tae Park, Jihee Han, Eunji Lee, Anna Le. Development of a mobile application based on the salutogenic model for self-management in adolescents with Moyamoya disease. Journal of pediatric nursing. vol 72. 2023-04-22. PMID:37086628. |
moyamoya disease (mmd) is a rare disease which has a high incidence of onset in adolescence. |
2023-04-22 |
2023-08-14 |
Not clear |